Patent AT-E401091-T1: [Translated] MODIFIED WHOLE CELL, CELL EXTRACT AND OMV BASED VACCINES

Description

Live vaccines, live-attenuated vaccines, dead vaccines, protein preparations for use in vaccines and OMVs for use in vaccines are free of CEACAM1-binding Opa, though max contain Opa variants that are antigenic but don't bind to CEACAM1.

Resources

Name Format Description Link
21 Access the complete Patent AT-E401091-T1: [Translated] MODIFIED WHOLE CELL, CELL EXTRACT AND OMV BASED VACCINES on the official website. https://pubchem.ncbi.nlm.nih.gov/patent/AT-E401091-T1

Tags

  • patent
  • chemistry
  • research
  • innovation
  • pubchem

Topics

Categories